Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial.
Mullish BH, Innes AJ, Roberts LA, Anim-Burton S, Webber L, Johnson NA, Ghani R, Farshi P, Khan AB, Kinsella F, Kottaridis P, Krishnamurthy P, Nicholson E, Palanicawandar R, Wheeler G, Davies F, Marchesi JR, Pavlů J. Mullish BH, et al. BMJ Open. 2024 Dec 22;14(12):e093120. doi: 10.1136/bmjopen-2024-093120. BMJ Open. 2024. PMID: 39773995 Clinical Trial.
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial.
Al-Shakhshir S, Quraishi MN, Mullish B, Patel A, Vince A, Rowe A, Homer V, Jackson N, Gyimah D, Shabir S, Manzoor S, Cooney R, Alrubaiy L, Quince C, van Schaik W, Hares M, Beggs AD, Efstathiou E, Rimmer P, Weston C, Iqbal T, Trivedi PJ. Al-Shakhshir S, et al. Among authors: mullish b. BMJ Open. 2025 Jan 6;15(1):e095392. doi: 10.1136/bmjopen-2024-095392. BMJ Open. 2025. PMID: 39762111 Free article.
Open label vancomycin in primary sclerosing cholangitis-inflammatory bowel disease: improved colonic disease activity and associations with changes in host-microbiome-metabolomic signatures.
Quraishi MN, Cheesbrough J, Rimmer P, Mullish BH, Sharma N, Efstathiou E, Acharjee A, Gkoutus G, Patel A, Marchesi JR, Camuzeaux S, Chappell K, Valdivia-Garcia MA, Ferguson J, Brookes M, Walmsley M, Rossiter A, van Schaik W, McInnes RS, Cooney R, Trauner M, Beggs A, Iqbal T, Trivedi PJ. Quraishi MN, et al. Among authors: mullish bh. J Crohns Colitis. 2024 Dec 14:jjae189. doi: 10.1093/ecco-jcc/jjae189. Online ahead of print. J Crohns Colitis. 2024. PMID: 39673746
Diverse phenotypes, consistent treatment: a study of 30,997 South Asian and White IBD patients using the UK IBD BioResource.
Balarajah S, Martinez-Gili L, Alexander JL, Mullish BH, Perry RW, Li JV, Marchesi JR; UK IBD BioResource Investigators; Parkes M, Orchard TR, Hicks LC, Williams HRT. Balarajah S, et al. Among authors: mullish bh. J Crohns Colitis. 2024 Dec 7:jjae186. doi: 10.1093/ecco-jcc/jjae186. Online ahead of print. J Crohns Colitis. 2024. PMID: 39657589
International consensus statement on microbiome testing in clinical practice.
Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Zeller G, Koren O, Tun H, Valles-Colomer M, Collado MC, Fischer M, Allegretti J, Iqbal T, Chassaing B, Keller J, Baunwall SM, Abreu M, Barbara G, Zhang F, Ponziani FR, Costello SP, Paramsothy S, Kao D, Kelly C, Kupcinskas J, Youngster I, Franceschi F, Khanna S, Vehreschild M, Link A, De Maio F, Pasolli E, Miguez AB, Brigidi P, Posteraro B, Scaldaferri F, Stojanovic MR, Megraud F, Malfertheiner P, Masucci L, Arumugam M, Kaakoush N, Segal E, Bajaj J, Leong R, Cryan J, Weersma RK, Knight R, Guarner F, Shanahan F, Cani PD, Elinav E, Sanguinetti M, de Vos WM, El-Omar E, Dorè J, Marchesi J, Tilg H, Sokol H, Segata N, Cammarota G, Gasbarrini A, Ianiro G. Porcari S, et al. Among authors: mullish bh. Lancet Gastroenterol Hepatol. 2024 Dec 5:S2468-1253(24)00311-X. doi: 10.1016/S2468-1253(24)00311-X. Online ahead of print. Lancet Gastroenterol Hepatol. 2024. PMID: 39647502 Review.
Derivation and validation of the BIMAST score for predicting the presence of fibrosis due to Metabolic dysfunction-associated steatotic liver disease among diabetic patients in the community.
Forlano R, Stanic T, Jayawardana S, Mullish BH, Yee M, Mossialos E, Goldin RD, Petta S, Tsochatzis E, Thursz MR, Manousou P. Forlano R, et al. Among authors: mullish bh. PLoS One. 2024 Sep 27;19(9):e0307500. doi: 10.1371/journal.pone.0307500. eCollection 2024. PLoS One. 2024. PMID: 39331620 Free PMC article.
3D printed rectal swabs for assessing the gut microbiome, metabolome and inflammation.
Perry RW, Mullish BH, Alexander JL, Shah R, Danckert NP, Blanco JM, Roberts L, Liu Z, Chrysostomou D, Radhakrishnan ST, Balarajah S, Barry R, Hicks LC, Williams HRT, Marchesi JR. Perry RW, et al. Among authors: mullish bh. Sci Rep. 2024 Jul 18;14(1):16613. doi: 10.1038/s41598-024-67457-0. Sci Rep. 2024. PMID: 39026025 Free PMC article.
146 results